Standard Glass Lining Technology Limited announced its results for the second quarter of FY26, marking another significant ...

Late Phase (USD 338.4B – USD 501.9B): Startups and technology-driven companies capture significant demand in emerging regions ...

In a significant move highlighting confidence in an innovative biotechnology platform, Renaissance Group LLC has established ...

Hilliard, the HHS spokesperson, told SFGATE on Tuesday that, “Secretary [Robert F.] Kennedy [Jr.] expects the highest ethical ...

CollaBraid is the first product the company aims to bring to market in 2026. The technology is a hybrid collagen suture — a thread-like material that surgeons use to stitch tissue together — for a ...

China's Angel Yeast has begun operating an 11,000-tonne production line for its yeast protein, bolstering the country's ...

The Nation has won overall best at the Ninth Open Forum on Agricultural Biotechnology (OFAB) Nigeria Media Awards. The ...

"It offers huge potential to boost food security, cut pesticide use, increase crop yields and enhance disease resistance and we are backing it with a multimillion-pound investment," the Department for ...

A biotech stock with strong FDA approval odds this November may see limited upside amid a full valuation and a pending lawsuit.

Compass Pathways, which is developing a psilocybin treatment for severe depression, said it now expects an earlier decision ...

2. Mergers and acquisitions are picking up: So far this year, buyouts have boosted several biotech stocks. Some standouts: Regulus Therapeutics went up 120%; 89bio went up 85%; Chimerix gained 69% and ...

The Council for Scientific and Industrial Research (CSIR) has assured Ghanaians that Genetically Modified (GM) foods, particularly ...